-
Symbol
-
CMMB on Nasdaq
-
Investment type
-
Equity / Ordinary Shares / American Depositary Shares
-
Latest Disclosed Shares Owned
-
969,807 shares
-
Security Ownership %
-
4.8%
ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP ownership in Chemomab Therapeutics Ltd. Ordinary Shares / American Depositary Shares (CMMB)
23 Jun 2025 - ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 969,807 shares of Chemomab Therapeutics Ltd. Ordinary Shares / American Depositary Shares (CMMB).
This represents 4.8% ownership of the company.
This is the first filing by OrbiMed Israel BioFund GP Limited Partnership disclosing ownership of Chemomab Therapeutics Ltd. Ordinary Shares / American Depositary Shares (CMMB).